Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists (ASA) physical status I and II who are to undergo elective general, urologic, orthopedic, plastic, or gynecologic surgery.~Exclusion Criteria:~* patients with age less than 18 yr or over 60 yr,~* emergency surgery,~* patients undergoing neurosurgical procedures,~* any procedure with adjunctive analgesia,~* any patient on chronic opiate use,~* females who are known to be pregnant,~* patients who had ingested psychotropic or sedative medication within one month of investigation,~* patients with personality disorders,~* weight greater than 20% of ideal, and~* any known contraindications to ketamine or propofol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Propofol (Type: ACTIVE_COMPARATOR): As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
- Ketofol (Type: EXPERIMENTAL): As part of the induction, patients will be given 20 mL syringe of an admixture called ketofol, which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.

Based on this trial design, predict the completion outcome and termination type (if applicable).